Seminars in Nephrology
Volume 29, Issue 2 , Pages 122-132 , March 2009

Bone Histomorphometry in Renal Osteodystrophy

  • Susan M. Ott, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Susan M. Ott, MD, Associate Professor, Department of Medicine, University of Washington Medical Center, Box 356426, 1959 Northeast Pacific St, Seattle, WA 98195-6426

References 

  1. Moe S, Drueke T, Cunningham J. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945–1953
  2. Ott S. Histomorphometric analysis of bone remodeling. In:  Bilezikian J,  Raisz L,  Ga R editor. Principles of bone biology. San Diego: Academic Press; 2002;p. 303–320
  3. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994;55:273–286
  4. Robling AG, Niziolek PJ, Baldridge LA, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin. J Biol Chem. 2008;283:5866–5875
  5. Eriksen EF, Gundersen HJG, Melsen F, Mosekilde L. Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Rel Res. 1984;5:243–252
  6. Jowsey J. Age changes in human bone. Clin Orthop Rel Res. 1960;17:210–217
  7. Osteoporosis and Bone Physiology [cited 2009 Feb 5]. Available from: http://courses.washington.edu/bonephys.
  8. Recker RR, Lappe JM, Davies KM, Heaney RP. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res. 2004;19:1628–1633
  9. Parfitt AM. Osteomalacia and related disorders. In:  Aviolo L,  Krane SM editor. Metabolic bone disease. Philadelphia: Saunders; 1990;p. 329–396
  10. Lindergard B, Johnell O, Nilsson BE, Wiklung PE. Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment. Nephron. 1985;39:122–129
  11. Chavassieux PM, Arlot ME, Meunier PJ. Intersample variation in bone histomorphometry: comparison between parameter values measured on two contiguous transiliac bone biopsies. Calcif Tissue Int. 1985;37:345–350
  12. Baker LR, Muir JW, Sharman VL, et al. Controlled trial of calcitriol in hemodialysis patients. Clin Nephrol. 1986;26:185–191
  13. Ferreira A, Frazao JM, Monier-Faugere MC, et al. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol. 2008;19:405–412
  14. Freemont AJ, Hoyland JA, Denton J. The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease. Clin Nephrol. 2005;64:428–437
  15. Hamdy NA, Kanis JA, Beneton MN, et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995;310:358–363
  16. Nordal KP, Dahl E. Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab. 1988;67:929–936
  17. Sanchez C, Lopez-Barea F, Sanchez-Cabezudo J, et al. Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry (A randomized multicentre study). Nephrol Dial Transplant. 2004;19:1587–1593
  18. Spasovski GB, Sikole A, Gelev S, et al. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant. 2006;21:2217–2224
  19. Malluche HH, Siami GA, Swanepoel C, et al. Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years. Clin Nephrol. 2008;70:284–295
  20. Joffe P, Heaf JG, Hyldstrup L. Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD. Kidney Int. 1994;46:838–846
  21. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol. 1988;30:57–62
  22. Araujo SM, Ambrosoni P, Lobao RR, et al. The renal osteodystrophy pattern in Brazil and Uruguay: an overview. Kidney Int Suppl. 2003;85:S54–S56
  23. Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol. 2000;13:437–443
  24. Torres A, Lorenzo V, Gonzalez-Posada JM. Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron. 1986;44:282–287
  25. Van Eps CL, Jeffries JK, Anderson JA, et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton). 2007;12:224–233
  26. DeVita MV, Rasenas LL, Bansal M, et al. Assessment of renal osteodystrophy in hemodialysis patients. Medicine (Baltimore). 1992;71:284–290
  27. Haas M, Leko-Mohr Z, Roschger P, et al. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am J Kidney Dis. 2002;39:580–586
  28. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EBF, Gokal R. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44:1071–1077
  29. Schober HC, Han ZH, Foldes AJ, et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol. 1998;9:1225–1233
  30. Boling E, Primavera C, Friedman G, King M, Bosserman LSE, Goodman WG. Non-invasive measurements of bone mass in adult renal osteodystrophy. Bone. 1993;14:409–413
  31. Fletcher S, Jones RG, Rayner HC, et al. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron. 1997;75:412–419

PII: S0270-9295(09)00006-0

doi: 10.1016/j.semnephrol.2009.01.005

Seminars in Nephrology
Volume 29, Issue 2 , Pages 122-132 , March 2009

Article Tools

* Image Usage & Resolution